Spain · Delayed Price · Currency is EUR BME:ACS Statistics
Total Valuation
BME:ACS has a market cap or net worth of EUR 33.07 billion. The enterprise value is 36.55 billion.
| Market Cap | 33.07B |
| Enterprise Value | 36.55B |
Important Dates
The next estimated earnings date is Monday, July 27, 2026.
| Earnings Date | Jul 27, 2026 |
| Ex-Dividend Date | Jan 21, 2026 |
Share Statistics
BME:ACS has 265.17 million shares outstanding. The number of shares has increased by 1.64% in one year.
| Current Share Class | 265.17M |
| Shares Outstanding | 265.17M |
| Shares Change (YoY) | +1.64% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 14.39% |
| Owned by Institutions (%) | 17.10% |
| Float | 141.32M |
Valuation Ratios
The trailing PE ratio is 32.58 and the forward PE ratio is 29.13. BME:ACS's PEG ratio is 1.75.
| PE Ratio | 32.58 |
| Forward PE | 29.13 |
| PS Ratio | 0.66 |
| PB Ratio | 6.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.55 |
| P/OCF Ratio | 10.38 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.33, with an EV/FCF ratio of 14.97.
| EV / Earnings | 36.87 |
| EV / Sales | 0.73 |
| EV / EBITDA | 13.33 |
| EV / EBIT | 20.76 |
| EV / FCF | 14.97 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 2.57.
| Current Ratio | 1.46 |
| Quick Ratio | 1.12 |
| Debt / Equity | 2.57 |
| Debt / EBITDA | 5.43 |
| Debt / FCF | 5.58 |
| Interest Coverage | 2.13 |
Financial Efficiency
Return on equity (ROE) is 24.61% and return on invested capital (ROIC) is 14.13%.
| Return on Equity (ROE) | 24.61% |
| Return on Assets (ROA) | 3.35% |
| Return on Invested Capital (ROIC) | 14.13% |
| Return on Capital Employed (ROCE) | 7.62% |
| Weighted Average Cost of Capital (WACC) | 6.67% |
| Revenue Per Employee | 300,419 |
| Profits Per Employee | 5,908 |
| Employee Count | 167,803 |
| Asset Turnover | 1.77 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:ACS has paid 459.87 million in taxes.
| Income Tax | 459.87M |
| Effective Tax Rate | 26.71% |
Stock Price Statistics
The stock price has increased by +122.54% in the last 52 weeks. The beta is 0.65, so BME:ACS's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +122.54% |
| 50-Day Moving Average | 125.05 |
| 200-Day Moving Average | 95.63 |
| Relative Strength Index (RSI) | 51.89 |
| Average Volume (20 Days) | 374,656 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:ACS had revenue of EUR 50.41 billion and earned 991.34 million in profits. Earnings per share was 3.83.
| Revenue | 50.41B |
| Gross Profit | 16.16B |
| Operating Income | 1.53B |
| Pretax Income | 1.72B |
| Net Income | 991.34M |
| EBITDA | 2.20B |
| EBIT | 1.53B |
| Earnings Per Share (EPS) | 3.83 |
Balance Sheet
The company has 10.48 billion in cash and 13.63 billion in debt, with a net cash position of -3.15 billion or -11.88 per share.
| Cash & Cash Equivalents | 10.48B |
| Total Debt | 13.63B |
| Net Cash | -3.15B |
| Net Cash Per Share | -11.88 |
| Equity (Book Value) | 5.29B |
| Book Value Per Share | 19.03 |
| Working Capital | 4.32B |
Cash Flow
In the last 12 months, operating cash flow was 3.18 billion and capital expenditures -743.76 million, giving a free cash flow of 2.44 billion.
| Operating Cash Flow | 3.18B |
| Capital Expenditures | -743.76M |
| Depreciation & Amortization | 673.14M |
| Net Borrowing | 550.03M |
| Free Cash Flow | 2.44B |
| FCF Per Share | 9.21 |
Margins
Gross margin is 32.06%, with operating and profit margins of 3.03% and 1.97%.
| Gross Margin | 32.06% |
| Operating Margin | 3.03% |
| Pretax Margin | 3.42% |
| Profit Margin | 1.97% |
| EBITDA Margin | 4.37% |
| EBIT Margin | 3.03% |
| FCF Margin | 4.84% |
Dividends & Yields
This stock pays an annual dividend of 2.01, which amounts to a dividend yield of 1.60%.
| Dividend Per Share | 2.01 |
| Dividend Yield | 1.60% |
| Dividend Growth (YoY) | 0.50% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 42.63% |
| Buyback Yield | -1.64% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 3.00% |
| FCF Yield | 7.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:ACS is 118.61, which is -5.11% lower than the current price. The consensus rating is "Buy".
| Price Target | 118.61 |
| Price Target Difference | -5.11% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 9.59% |
| EPS Growth Forecast (3Y) | 17.85% |
Stock Splits
The last stock split was on June 10, 2004. It was a forward split with a ratio of 3.000003.
| Last Split Date | Jun 10, 2004 |
| Split Type | Forward |
| Split Ratio | 3.000003 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |